UPSA reveals potent, orally active and well-tolerated antiinflammatory/analgesic agents Jan. 28, 1999
Novel triptolide derivatives from HMR for rheumatoid arthritis and other autoimmune diseases Jan. 28, 1999
Cypress Bioscience to collaborate with Fresenius; FDA requests more information for Prosorba Column Jan. 27, 1999